Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Ataxion
25 First Street, Suite 303
Cambridge, MA 02141

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic diseases. Located in Cambridge, Massachusetts, Ataxion was founded in April 2013 out of the Atlas Venture seed program by Dr. Josh Resnick and Atlas Venture Development Corporation Managing Director and Ataxion Board Member David Grayzel, MD.

Key Contact
Name
Joshua Resnick
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
03/18/14 $17,000,000 Series A Atlas Venture
Biogen Idec


Featured Reading